InMed Pharmaceuticals

-$0.0176 (-2.23%) Today
+$0.0024 (+0.31%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell INM and other ETFs, options, and stocks.

About INM

InMed Pharmaceuticals, Inc. engages in the provision of biopharmaceutical research. It is also involved in cannabinoid-based therapies and a biosynthesis system for the manufacturing of pharmaceutical-grade cannabinoids.

CEO
Eric A. Adams
Employees
—
Headquarters
Vancouver, British Columbia
Founded
1981

INM Key Statistics

Market cap
11.09M
Price-Earnings ratio
—
Dividend yield
—
Average volume
64.62K
High today
$0.8295
Low today
$0.7558
Open price
$0.8295
Volume
36.66K
52 Week high
$3.51
52 Week low
$0.6521

INM Earnings

-$0.41
-$0.27
-$0.14
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
— per share
Actual
-$0.25 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure